The final, formatted version of the article will be published soon. Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are increasingly prescribed for heart failure and chronic kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback